Dopamine has also been identified as an important phenylalanine-derived metabolite in tumor microenvironment, which was found to either promote or inhibit tumor cell growth through different receptor-mediated signaling pathways (e.g., G protein-coupled dopamine D2 receptor (DRD2)) [61]. The gene discussed is DRD2; the disease is neoplasm.